Skip to content

Aurobindo Pharma trades 2% down as US FDA spots issues in Telangana unit

Aurobindo Pharma subsidiary#39;s Telangana plant was slapped with 7 observations by the US FDA after its inspection of the unit from February 19-29.

Read More

​ Aurobindo Pharma subsidiary#39;s Telangana plant was slapped with 7 observations by the US FDA after its inspection of the unit from February 19-29. Aurobindo Pharma subsidiary#39;s Telangana plant was slapped with 7 observations by the US FDA after its inspection of the unit from February 19-29.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish